Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment

NCT02705651 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neuroendocrine Tumors in MEN1

Interventions

DRUG: Somatostatin-Analog

Sponsor

Medical University of Vienna